Senior Scientist I, Computational Biology (targetID)

HAYA Therapeutics is a precision therapeutics company based at the life sciences park Biopôle SA in Lausanne, Switzerland, and JLABS, San Diego, USA. Haya Therapeutics is developing novel tissue-specific antisense oligonucleotide drugs targeting long noncoding RNAs in fibrotic diseases including heart, lungs, kidney, liver, and cancers.

• Purpose of the role:

Execute Target Discovery and Validation activities within the Data Science team to identify and validate cell-state driving disease-modifying lncRNAs and regulatory elements by integrating multi-omics transcriptomics and epigenomics datasets, with main focus on immunology and inflammatory indications

• Accountabilities
• Preprocess and analyze raw multi-omics datasets (including bulk/single-cell/single-nuclei RNA-seq, ATAC-seq, PRO-seq, CUT&RUN, 3D genomics) to characterize the regulatory genome driving cell states and extract the features to perform target identification.
• Integrate human genomic, genetic, and epigenetic datasets (including GWAS, eQTLs, and chromatin conformation annotations) with internal transcriptomic pipelines to identify potent cell-state driving lncRNA targets.
• Translate high-dimensional omics analysis and results into clear, biologically grounded scientific presentations and documentation to facilitate strategic alignment, influence multi-disciplinary program stakeholders, and support executive decisions.

Requirements

• Required Knowledge and Experience

Essential Qualifications & Technical Capabilities (Must-Haves)

• PhD in Computational Biology, Bioinformatics, Computer Science, Genomics, or a related quantitative or life sciences field with a robust computational focus; or equivalent demonstrated capability and technical depth.

• Proficient programming skills in R or Python, supported by strong data hygiene, and a desire to build shared reproducible toolkits and pipelines.

• Experience on the identification of novel targets, demonstrating a strong drive to design and leverage computational workflows with minimal supervision.

• Deep technical proficiency in preprocessing, integrating, and analyzing multi-omics datasets, specifically bulk and single-cell/single-nuclei RNA-seq, ATAC-seq, PRO-seq, and CUT&RUN, to define cell states and identify biological drivers within the regulatory genome.

• Excellent scientific understanding of gene regulation, transcriptomics, and the non-coding genome (in particular lncRNAs) and gene regulatory networks.

• Proven capability in presenting complex multi-omics statistical analyses, and data science concepts in a clear, narrative-driven manner to both technical, biological, and non-expert stakeholders, serving as a bridge between dry and wet lab activities.

Desirable Experience & Specialized Expertise (Nice-to-Haves)

• Biological expertise in immunology, inflammatory indications, or immune cell profiling, with the ability to contextualize transcriptomic discoveries in the frame of chronic pathology (highly desired).

• Work within scalable server and cloud automation standards, write reproducible scripting templates, and keeps data science analysis standards that raise the technological bar for the entire Data Science & AI department.

• Demonstrated history of fostering a collaborative scientific culture by providing code reviews, guiding junior analysts on data science best practices, and ensuring strict adherence to reproducible computational biology.

HAYA Therapeutics is an Equal Opportunity Employer committed to fostering a diverse, inclusive, and equitable workplace where all individuals feel valued and empowered. We provide equal employment opportunities to all qualified applicants and employees without regard to race, color, religion, sex (including pregnancy, sexual orientation, gender identity, or gender expression), national origin, ancestry, age, marital or familial status, veteran status, disability, genetic information, or any other characteristic protected by applicable federal, state, or local laws.

We prohibit discrimination and harassment of any kind and are committed to ensuring fair and equitable treatment in all aspects of recruitment, hiring, promotion, compensation, benefits, training, and career development. At HAYA, we believe that diversity of thought, experience, and background drives innovation and strengthens our mission to transform patient care through cutting-edge RNA-based therapeutics.

Notice to Recruitment Agencies & Search Firms

HAYA Therapeutics operates a Preferred Supplier List (PSL) and manages all recruitment directly through our Human Resources team. We do not accept unsolicited resumes or speculative CVs from third-party agencies, search firms, or recruiters. Any unsolicited candidates or CVs submitted through non-approved channels, directly to HAYA employees, or without a fully executed recruitment agreement in place will be considered property of HAYA Therapeutics. HAYA Therapeutics will not pay any fee, liability, or finder's fee for candidates submitted under these circumstances.